Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Arrowhead Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 31 Oct 2023 | GSK and Arrowhead Pharma to Enter into Licensing Agreement with Janssen Pharma | Licensing Agreement |
Arrowhead Pharmaceuticals Inc
GSK plc |
Janssen Pharmaceuticals Inc
|
| 01 Mar 2023 | Arrowhead Pharmaceuticals Inc Enters Phase I/II Clinical Trial Agreement with Novotech Australia Pty Ltd for ARO-RAGE (GDCT0501485) | Contract Service Agreement |
Arrowhead Pharmaceuticals Inc
|
Novotech Australia Pty Ltd
|
| 09 Nov 2022 | Royalty Pharma Acquires Royalty Interest in Olpasiran from Arrowhead Pharma | Asset Transaction |
Royalty Pharma Plc
|
Arrowhead Pharmaceuticals Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer